Biosimilar Interchangeability Designation Would Be Nixed Under Biden Proposal

 
• By Derrick Gingery
  
budget
The FDA would receive about $7.2bn in budget authority and user fees in Biden's FY 2025 budget request • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products